Hemab
Hemab Therapeutics is pioneering the first preventative treatments for rare bleeding and thrombotic disorders to ensure no patient is ever left behind
Seedtable Score
46
Startups
4
Funding Rounds
$407.0m
Money raised
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Hemab has raised a total of $407m in funding over 4 rounds.
Key Insights:
- Hemab Series C Round, October 2025: $157m
- Hemab February 2023 Series B Funding Round: $140m
- Hemab Series A round, July 2021: $55m
- Hemab July 2021 Series A Funding Round: $55m
Hemab Series C Round, October 2025
$157m
Hemab February 2023 Series B Funding Round
$140m
Hemab Series A round, July 2021
$55m
Hemab July 2021 Series A Funding Round
$55m
Industries
Hemab is active in the following industries: